Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

MeiraGTx Holdings plc (MGTX)

7.55   -0.2 (-2.58%) 06-26 18:54
Open: 7.85 Pre. Close: 7.75
High: 8.04 Low: 7.47
Volume: 228,766 Market Cap: 338(M)
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative diseases, such as amyotrophic lateral sclerosis; and Parkinson's diseases. Its programs in clinical development include Phase 1/2 clinical stage programs in Achromatopsia, X-Linked Retinitis Pigmentosa, RPE65-deficiency, and radiation-induced Xerostomia, as well as Parkinson's program. The company also focuses on initiating a clinical program in xerostomia related to Sjogren's syndrome and have preclinical programs in neurodegenerative diseases. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. to develop regulatable gene therapy treatment using the company's proprietary riboswitch technology. MeiraGTx Holdings plc was incorporated in 2015 and is based in New York, New York.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 8.06 - 8.1 8.1 - 8.13
Low: 7.37 - 7.42 7.42 - 7.46
Close: 7.48 - 7.56 7.56 - 7.62

Technical analysis

as of: 2022-06-24 4:41:36 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 9.32     One year: 10.33
Support: Support1: 6.59    Support2: 5.48
Resistance: Resistance1: 7.98    Resistance2: 8.85
Pivot: 7.58
Moving Average: MA(5): 7.59     MA(20): 7.71
MA(100): 11.52     MA(250): 14.58
MACD: MACD(12,26): -0.5     Signal(9): -0.6
Stochastic oscillator: %K(14,3): 51.8     %D(3): 51.6
RSI: RSI(14): 41.8
52-week: High: 24.89  Low: 6.59
Average Vol(K): 3-Month: 154 (K)  10-Days: 177 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ MGTX ] has closed above bottom band by 47.5%. Bollinger Bands are 27.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 06 Jun 2022
MeiraGTx Holdings plc (NASDAQ:MGTX) Insider Acquires $39,500.00 in Stock - MarketBeat

Mon, 30 May 2022
Down More Than 40%: Analysts Say These 2 Beaten-Down Stocks Are Oversold - TipRanks

Wed, 25 May 2022
Noteworthy Wednesday Option Activity: AMGN, SPLK, MGTX - Nasdaq

Thu, 12 May 2022
MeiraGTx Reports First Quarter 2022 Financial and Operational Results - Yahoo Finance

Fri, 29 Apr 2022
MeiraGTx Holdings (NASDAQ:MGTX) Is In A Good Position To Deliver On Growth Plans - Simply Wall St

Thu, 10 Mar 2022
MeiraGTx Reports Fourth Quarter and Full Year 2021 Financial and Operational Results - GlobeNewswire

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 44 (M)
Shares Float 25 (M)
% Held by Insiders 12.5 (%)
% Held by Institutions 65.8 (%)
Shares Short 1,970 (K)
Shares Short P.Month 1,890 (K)

Stock Financials

EPS -1.87
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 4.23
Profit Margin (%) -211.1
Operating Margin (%) -194.2
Return on Assets (ttm) -13.4
Return on Equity (ttm) -37.6
Qtrly Rev. Growth 455.5
Gross Profit (p.s.) 0.84
Sales Per Share 0.84
EBITDA (p.s.) -1.47
Qtrly Earnings Growth 0
Operating Cash Flow -11 (M)
Levered Free Cash Flow -33 (M)

Stock Valuations

PE Ratio -4.06
PEG Ratio -1.9
Price to Book value 1.78
Price to Sales 8.9
Price to Cash Flow -31.88

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.